These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A possible role for propranolol in the treatment of renal osteodystrophy. Caro JF; Besarab A; Burke JF; Glennon JA Lancet; 1978 Aug; 2(8087):451-4. PubMed ID: 79809 [TBL] [Abstract][Full Text] [Related]
4. Suppression of secondary hyperparathyroidism by propranolol in renal failure patients. Besarab A; Caro JF; Ihle BU; Burke JF; Glennon JA; Fischer JA Nephron; 1981; 27(3):127-33. PubMed ID: 7219643 [TBL] [Abstract][Full Text] [Related]
5. Prevention of renal osteodystrophy. Baker LR Miner Electrolyte Metab; 1991; 17(4):240-9. PubMed ID: 1813786 [TBL] [Abstract][Full Text] [Related]
6. Use of oral and parenteral calcitriol in the treatment of renal osteodystrophy. Coburn JW Kidney Int Suppl; 1990 Sep; 29():S54-61. PubMed ID: 2214548 [No Abstract] [Full Text] [Related]
7. Early dietary phosphorus restriction and calcium supplementation in the prevention of renal osteodystrophy. Maschio G; Tessitore N; D'Angelo A; Bonucci E; Lupo A; Valvo E; Loschiavo C; Fabris A; Morachiello P; Previato G; Fiaschi E Am J Clin Nutr; 1980 Jul; 33(7):1546-54. PubMed ID: 7395775 [No Abstract] [Full Text] [Related]
8. [Prevention and treatment of renal osteodystrophy: present and future]. Fernández E; Craver L Nefrologia; 2006; 26 Suppl 3():19-27. PubMed ID: 17469423 [No Abstract] [Full Text] [Related]
9. Low-dose vitamin D analogues for renal osteodystrophy. Lancet; 1989 Jun; 1(8651):1364-5. PubMed ID: 2567378 [No Abstract] [Full Text] [Related]
10. Progress of renal osteodystrophy during continuous ambulatory peritoneal dialysis. Buccianti G; Bianchi ML; Valenti G Clin Nephrol; 1984 Dec; 22(6):279-83. PubMed ID: 6525771 [TBL] [Abstract][Full Text] [Related]
11. Target levels for serum phosphorus and parathyroid hormone. Qunibi W; Kalantar-Zadeh K Semin Dial; 2011; 24(1):29-33. PubMed ID: 21324001 [No Abstract] [Full Text] [Related]
12. Control of mineral metabolism in CAPD patients. Delmez JA Blood Purif; 1989; 7(2-3):167-80. PubMed ID: 2663036 [TBL] [Abstract][Full Text] [Related]
13. The need to treat predialysis patients. Hamdy NA Nephrol Dial Transplant; 1995; 10 Suppl 4():19-22; discussion 37-43. PubMed ID: 7478145 [No Abstract] [Full Text] [Related]
14. [Prophylaxis of renal osteodystrophy]. Przedlacki J Pol Arch Med Wewn; 2003 Oct; 110(4):1227-34. PubMed ID: 14699682 [No Abstract] [Full Text] [Related]
15. Mineral and bone disorders in patients on dialysis: physiology and clinical consequences. McCarley PB; Arjomand M Nephrol Nurs J; 2008; 35(1):59-64. PubMed ID: 18372764 [TBL] [Abstract][Full Text] [Related]